200 1st Street SW
752 articles with Mayo Clinic
Elysium Health™ Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard
Elysium Health, Inc.™ has entered into an exclusive license agreement with Mayo Clinic and Harvard University.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Researchers at the Mayo Clinic, led by geneticist Fergus Couch, identified specific genes associated with triple-negative breast cancer. Triple-negative breast cancer is generally difficult to treat and has a lower five-year survival rate than other types of breast cancer.
A*STAR Institute and Mayo Clinic Identify Key Protein to Convert Skin Cells into Other Types of C...
7/12/2018A*STAR’s Institute of Molecular & Cell Biology (IMCB) in Singapore, along with the Mayo Clinic, identified a key epigenetic protein called H3.3 that helps convert skin cells into other types of cells via cellular reprogramming.
Agreement through 2023 emphasizes high-value care, strategic collaboration
Exact Sciences, Mayo Clinic Researchers Identify Blood-Based DNA Biomarker Panel to Accurately Diagnose Hepatocellular Carcinoma
Data Presented at Digestive Disease Week Show Panel of Six Biomarkers is 95 Percent Sensitive for Most Common Type of Liver Cancer
Automated Breast Density from Volpara Solutions Strongly Predicts Risk of Screen-Detected and Interval Cancers
Research from University of California San Francisco and the Mayo Clinic Supports the Use of Fully Automated Volpara®Density™ Software to Inform Women of their Breast Density
Dr. Limburg is a gastroenterologist and a professor of medicine at Mayo Clinic. He is also a co-leader of the Cancer Prevention and Control program within Mayo Clinic Cancer Center.
SkylineDx Inks Joint Development Agreement with Mayo Clinic to Develop Diagnostic Tests for Melanoma
For SkylineDx, the collaboration with the renowned Mayo Clinic is an important milestone as it allows the company to develop new diagnostic tests and extend its product offering for a broader group of patients and clinicians.
The Recovery Force platform embeds shape changing fibers into garments and footwear to create lightweight wearable active compressions providing users with improved circulation and the mobility necessary for a quicker recovery.
WuXi AppTec and Mayo Clinic announced today a joint venture to co-develop and deliver clinical diagnostic services in China.
Veritas Genetics Launches Collaboration With Mayo Clinic to Integrate Whole Genome Sequencing Into Clinical Care
Veritas Genetics, The Genome Company, and Mayo Clinic are entering into an agreement to make whole genome sequencing broadly available to healthy individuals.
Corindus to Participate With Mayo Clinic in Preclinical Study of Remote Control Robotics for Percutaneous Coronary Interventions Remote Treatment Capabilities
Corindus announced today that it is working with Mayo Clinic in a preclinical study about use of telestenting. Telestenting, or the remote robotic treatment for percutaneous coronary intervention (PCI).
PathoQuest and Mayo Clinic Enter Into an Agreement to Conduct Study of iDTECT Blood in Patients With Febrile Neutropenia
PathoQuest announced that it will conduct research with Mayo Clinic to study the company’s proprietary iDTECT Blood test.
Mayo Clinic to Begin Prospective Clinical Study With Medibio Technology for Expanded Market Opportunities
This initial study, undertakes the prospective diagnosis and longitudinal monitoring of both unipolar and bipolar depression, along with the depressive subtypes (melancholic and atypical).
sphingotec Announces Collaboration With Mayo Clinic for Evaluation and Use of Biomarkers to Improve Diagnosis of Certain Diseases, Including Kidney Disease, Breast Cancer, Sepsis, and Cardiovascular Disease
Through this agreement, Mayo Clinic will evaluate the biomarkers penKid and three others for research and potential routine clinical use.
Evelo Biosciences and Mayo Clinic Collaborate to Advance Monoclonal Microbials for the Treatment of Inflammatory and Neuroinflammatory Diseases
In the published studies, the monoclonal microbial, an anaerobic commensal microbe isolated from a human biopsy sample, led to a decrease in activity of Th17 inflammatory cells and an increase in the activity and frequency of regulatory T-cells.
MediPines announced today that it has acquired medical technology designed to reduce respiratory complications in post-surgical patients by preventing oxygen desaturations.